Victor Manuel Saure Sarría Ariel D Arencibia Vívian D'Afonseca
10.1177/2324709620942606
J Investig Med High Impact Case Rep
2020 Jan-Dec;8:2324709620942606.
her2-positive breast cancer combined chemotherapy inflammatory bca component supraclavicular lymphadenopathy
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/32720808/
Antibodies, Monoclonal, Humanized / administration & dosage Antineoplastic Combined Chemotherapy Protocols / administration & dosage Breast Neoplasms / drug therapy Capecitabine / administration & dosage Lymphadenopathy / drug therapy Trastuzumab / administration & dosage
Antibodies, Monoclonal, Humanized / administration & dosage Antineoplastic Combined Chemotherapy Protocols / administration & dosage Breast Neoplasms / drug therapy Capecitabine / administration & dosage Lymphadenopathy / drug therapy Trastuzumab / administration & dosage Case Reports Administration, Intravenous Administration, Oral Adult Drug Administration Schedule Female Humans Injections, Subcutaneous Neoplasm Metastasis Neoplasm Recurrence, Local / drug therapy Receptor, ErbB-2 / biosynthesis Treatment Outcome Antibodies, Monoclonal, Humanized Capecitabine Receptor, ErbB-2 pertuzumab Trastuzumab
PMC7388084
32720808
Xeloda Oral, Trastuzumab, and Pertuzumab Combined Drug Therapy Reduced Cervical Lymphadenopathy and Dermal Involvement in Patient With Recurrent Breast Cancer: Case Report
2020